Show simple item record

dc.contributor.authorYilmaz, N
dc.contributor.authorTurker, H
dc.contributor.authorErelel, M
dc.contributor.authorIlvan, A
dc.contributor.authorGoylusun, V
dc.contributor.authorKuyucu, TY
dc.contributor.authorKosar, F
dc.contributor.authorSoysal, F
dc.contributor.authorGur, A
dc.contributor.authorUnutmaz, S
dc.contributor.authorOzturk, S
dc.contributor.authorAkman, M
dc.contributor.authorMusellim, B
dc.contributor.authorUmut, S
dc.contributor.authorTutluoglu, B
dc.contributor.authorTosun, GA
dc.contributor.authorErk, M
dc.contributor.authorYildirim, N
dc.contributor.authorVahapoglu, H
dc.contributor.authorArseven, O
dc.date.accessioned2021-03-03T15:19:16Z
dc.date.available2021-03-03T15:19:16Z
dc.date.issued1999
dc.identifier.citationUmut S., Tutluoglu B., Tosun G., Musellim B., Erk M., Yildirim N., Vahapoglu H., Yilmaz N., Arseven O., Turker H., et al., "Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor", JOURNAL OF CHEMOTHERAPY, cilt.11, sa.3, ss.211-214, 1999
dc.identifier.issn1120-009X
dc.identifier.othervv_1032021
dc.identifier.otherav_3e618087-86cb-47ef-a6c0-3e102594c187
dc.identifier.urihttp://hdl.handle.net/20.500.12627/45794
dc.identifier.urihttps://doi.org/10.1179/joc.1999.11.3.211
dc.description.abstractAcute exacerbations, most of which are due to lower respiratory tract infections, cause great morbidity and mortality in patients with chronic obstructive pulmonary disease (COPD) and most of these are due to lower respiratory tract infections. The aim of this study was to determine the causative organism and the effects of azithromycin, ampicillin sulbactam (sultamicillin), ciprofloxacin and cefaclor monohydrate therapy in COPD. One hundred and six patients with COPD in acute exacerbation were randomized into four groups for empiric antibiotic treatment following lung function tests and sputum examination. The most common strains isolated from sputum were Haemophilus influenzae (30.8%), Streptoccocus pneumoniae (12%) and Moraxella catarrhalis (7.7%). Azithromycin, sultamicillin, ciprofloxacin and cefaclor monohydrate were found to be effective in treating COPD exacerbations.
dc.language.isoeng
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectPatoloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectBiyoloji ve Biyokimya
dc.subjectPATOLOJİ
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleDetermination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor
dc.typeMakale
dc.relation.journalJOURNAL OF CHEMOTHERAPY
dc.contributor.department, ,
dc.identifier.volume11
dc.identifier.issue3
dc.identifier.startpage211
dc.identifier.endpage214
dc.contributor.firstauthorID57357


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record